Reminder for Integer Holdings Shareholder Class Action
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Should l Buy ITGR?
Source: Globenewswire
- Class Action Notification: Rosen Law Firm reminds investors who purchased Integer Holdings stock between July 25, 2024, and October 22, 2025, to apply to be lead plaintiff by February 9, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Integer overstated its competitive position in the electrophysiology device market and failed to disclose a sustained decline in sales of two of its devices, resulting in investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and was ranked first by ISS for the number of securities class action settlements in 2017, demonstrating its expertise in this field.
- Investor Selection Advice: Investors are advised to carefully choose law firms with a proven track record to ensure effective legal support in class actions, avoiding those that merely act as intermediaries without substantial litigation experience.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ITGR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ITGR
Wall Street analysts forecast ITGR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ITGR is 93.38 USD with a low forecast of 75.00 USD and a high forecast of 140.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
4 Buy
6 Hold
0 Sell
Moderate Buy
Current: 85.520
Low
75.00
Averages
93.38
High
140.00
Current: 85.520
Low
75.00
Averages
93.38
High
140.00
About ITGR
Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Reminder for Integer Holdings Shareholder Class Action
- Class Action Notification: Rosen Law Firm reminds investors who purchased Integer Holdings stock between July 25, 2024, and October 22, 2025, to apply to be lead plaintiff by February 9, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Integer overstated its competitive position in the electrophysiology device market and failed to disclose a sustained decline in sales of two of its devices, resulting in investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and was ranked first by ISS for the number of securities class action settlements in 2017, demonstrating its expertise in this field.
- Investor Selection Advice: Investors are advised to carefully choose law firms with a proven track record to ensure effective legal support in class actions, avoiding those that merely act as intermediaries without substantial litigation experience.
See More
Integer Holdings Faces Class Action Securities Lawsuit
- Lawsuit Background: Levi & Korsinsky LLP has notified investors that Integer Holdings Corporation (NYSE: ITGR) is facing a class action securities lawsuit for alleged fraud between July 25, 2024, and October 22, 2025, aimed at recovering losses for affected investors.
- Allegations Details: The complaint alleges that defendants made false statements, claiming Integer materially overstated its competitive position in the electrophysiology manufacturing market, while experiencing a sustained decline in sales of two electrophysiology devices contrary to its claims of strong customer demand.
- Market Impact: As a result of these issues, Integer mischaracterized its electrophysiology devices as long-term growth drivers for its cardio & vascular segment, leading to materially false and misleading statements about the company's business and prospects, which could negatively impact stock prices.
- Participation Conditions: Affected investors must request to be appointed as lead plaintiff by February 9, 2026, and participation in the lawsuit incurs no costs; class members may be entitled to compensation without any out-of-pocket expenses.
See More
Integer Holdings Faces Securities Class Action Lawsuit
- Lawsuit Deadline: ClaimsFiler reminds investors that those who purchased Integer Holdings shares between July 25, 2024, and October 22, 2025, must file lead plaintiff applications by February 9, 2026, to participate in the securities class action lawsuit against the company.
- Sales Guidance Cut: On October 23, 2025, Integer Holdings lowered its full-year 2025 sales guidance to between $1.840 billion and $1.854 billion, significantly below analyst expectations, with projected net sales growth of -2% to 2% for 2026, indicating slower market adoption of its products than anticipated.
- Stock Price Plunge: Following the sales guidance cut, Integer Holdings' stock price plummeted by $35.22, or over 32%, from a closing price of $109.11 on October 22, 2025, to $73.89 on October 23, reflecting a pessimistic market outlook on the company's future.
- Legal Accountability: The lawsuit alleges that Integer and certain executives failed to disclose material information during the class period, violating federal securities laws, which could expose the company to significant legal and financial risks, impacting its future market performance.
See More
Class Action Filed Against Integer Holdings for Securities Fraud
- Lawsuit Background: Bleichmar Fonti & Auld LLP has filed a class action lawsuit against Integer Holdings and certain executives, alleging securities fraud that led to a significant stock drop due to potential violations of federal securities laws.
- Stock Price Plunge: Integer disclosed on October 23, 2025, that it lowered its 2025 sales guidance to between $1.840 billion and $1.854 billion, significantly below analyst expectations, causing its stock price to plummet from $109.11 to $73.89, a drop of over 32%.
- Market Performance Missteps: Despite the company's repeated claims of growth in its electrophysiology devices, actual demand and revenue sharply declined, directly contradicting public assurances and exacerbating investor dissatisfaction.
- Legal Options: Investors are encouraged to apply to lead the case by February 9, 2026, with BFA offering representation on a contingency fee basis, ensuring no upfront costs for shareholders and minimizing their legal risks.
See More
Notice of Class Action Lawsuit for Integer Holdings Shareholders
- Lawsuit Background: The Gross Law Firm has issued a notice encouraging shareholders who purchased Integer Holdings (NYSE: ITGR) shares between July 25, 2024, and October 22, 2025, to contact them regarding potential lead plaintiff appointment, indicating significant legal risks for the company.
- False Statement Allegations: The lawsuit alleges that Integer materially overstated its competitive position in the electrophysiology manufacturing market, and despite claims of strong visibility into customer demand, the company was experiencing a sustained deterioration in sales, impacting its financial health.
- Market Reaction Impact: The mischaracterization of electrophysiology devices as long-term growth drivers for the cardiovascular segment may lead to diminished investor confidence in the company's future prospects, potentially affecting stock prices negatively.
- Shareholder Action Steps: Shareholders must register for the class action by February 9, 2026, and upon registration, they will receive status updates throughout the lifecycle of the case, ensuring they remain informed about the proceedings.
See More
Integer Holdings Faces Class Action Securities Lawsuit
- Lawsuit Background: Levi & Korsinsky LLP has notified investors that Integer Holdings Corporation is facing a class action securities lawsuit aimed at recovering losses for investors affected between July 25, 2024, and October 22, 2025.
- Allegations of False Statements: The lawsuit alleges that Integer materially overstated its competitive position in the rapidly growing electrophysiology manufacturing market and concealed deteriorating sales of its electrophysiology devices, misleading investors about the company's prospects.
- Market Impact: The positive statements regarding the company's business and operations are deemed materially false and misleading, potentially leading to significant financial losses for investors and adversely affecting the company's stock price and market reputation.
- Participation Conditions: Affected investors must request to be appointed as lead plaintiff by February 9, 2026, and participation in the lawsuit incurs no costs, indicating the case could have significant implications for investor rights.
See More
Reminder for Integer Holdings Shareholder Class Action
- Class Action Notification: Rosen Law Firm reminds investors who purchased Integer Holdings stock between July 25, 2024, and October 22, 2025, to apply to be lead plaintiff by February 9, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Integer overstated its competitive position in the electrophysiology device market and failed to disclose a sustained decline in sales of two of its devices, resulting in investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and was ranked first by ISS for the number of securities class action settlements in 2017, demonstrating its expertise in this field.
- Investor Selection Advice: Investors are advised to carefully choose law firms with a proven track record to ensure effective legal support in class actions, avoiding those that merely act as intermediaries without substantial litigation experience.
See More
Integer Holdings Faces Class Action Securities Lawsuit
- Lawsuit Background: Levi & Korsinsky LLP has notified investors that Integer Holdings Corporation (NYSE: ITGR) is facing a class action securities lawsuit for alleged fraud between July 25, 2024, and October 22, 2025, aimed at recovering losses for affected investors.
- Allegations Details: The complaint alleges that defendants made false statements, claiming Integer materially overstated its competitive position in the electrophysiology manufacturing market, while experiencing a sustained decline in sales of two electrophysiology devices contrary to its claims of strong customer demand.
- Market Impact: As a result of these issues, Integer mischaracterized its electrophysiology devices as long-term growth drivers for its cardio & vascular segment, leading to materially false and misleading statements about the company's business and prospects, which could negatively impact stock prices.
- Participation Conditions: Affected investors must request to be appointed as lead plaintiff by February 9, 2026, and participation in the lawsuit incurs no costs; class members may be entitled to compensation without any out-of-pocket expenses.
See More
Integer Holdings Faces Securities Class Action Lawsuit
- Lawsuit Deadline: ClaimsFiler reminds investors that those who purchased Integer Holdings shares between July 25, 2024, and October 22, 2025, must file lead plaintiff applications by February 9, 2026, to participate in the securities class action lawsuit against the company.
- Sales Guidance Cut: On October 23, 2025, Integer Holdings lowered its full-year 2025 sales guidance to between $1.840 billion and $1.854 billion, significantly below analyst expectations, with projected net sales growth of -2% to 2% for 2026, indicating slower market adoption of its products than anticipated.
- Stock Price Plunge: Following the sales guidance cut, Integer Holdings' stock price plummeted by $35.22, or over 32%, from a closing price of $109.11 on October 22, 2025, to $73.89 on October 23, reflecting a pessimistic market outlook on the company's future.
- Legal Accountability: The lawsuit alleges that Integer and certain executives failed to disclose material information during the class period, violating federal securities laws, which could expose the company to significant legal and financial risks, impacting its future market performance.
See More
Class Action Filed Against Integer Holdings for Securities Fraud
- Lawsuit Background: Bleichmar Fonti & Auld LLP has filed a class action lawsuit against Integer Holdings and certain executives, alleging securities fraud that led to a significant stock drop due to potential violations of federal securities laws.
- Stock Price Plunge: Integer disclosed on October 23, 2025, that it lowered its 2025 sales guidance to between $1.840 billion and $1.854 billion, significantly below analyst expectations, causing its stock price to plummet from $109.11 to $73.89, a drop of over 32%.
- Market Performance Missteps: Despite the company's repeated claims of growth in its electrophysiology devices, actual demand and revenue sharply declined, directly contradicting public assurances and exacerbating investor dissatisfaction.
- Legal Options: Investors are encouraged to apply to lead the case by February 9, 2026, with BFA offering representation on a contingency fee basis, ensuring no upfront costs for shareholders and minimizing their legal risks.
See More
Notice of Class Action Lawsuit for Integer Holdings Shareholders
- Lawsuit Background: The Gross Law Firm has issued a notice encouraging shareholders who purchased Integer Holdings (NYSE: ITGR) shares between July 25, 2024, and October 22, 2025, to contact them regarding potential lead plaintiff appointment, indicating significant legal risks for the company.
- False Statement Allegations: The lawsuit alleges that Integer materially overstated its competitive position in the electrophysiology manufacturing market, and despite claims of strong visibility into customer demand, the company was experiencing a sustained deterioration in sales, impacting its financial health.
- Market Reaction Impact: The mischaracterization of electrophysiology devices as long-term growth drivers for the cardiovascular segment may lead to diminished investor confidence in the company's future prospects, potentially affecting stock prices negatively.
- Shareholder Action Steps: Shareholders must register for the class action by February 9, 2026, and upon registration, they will receive status updates throughout the lifecycle of the case, ensuring they remain informed about the proceedings.
See More
Integer Holdings Faces Class Action Securities Lawsuit
- Lawsuit Background: Levi & Korsinsky LLP has notified investors that Integer Holdings Corporation is facing a class action securities lawsuit aimed at recovering losses for investors affected between July 25, 2024, and October 22, 2025.
- Allegations of False Statements: The lawsuit alleges that Integer materially overstated its competitive position in the rapidly growing electrophysiology manufacturing market and concealed deteriorating sales of its electrophysiology devices, misleading investors about the company's prospects.
- Market Impact: The positive statements regarding the company's business and operations are deemed materially false and misleading, potentially leading to significant financial losses for investors and adversely affecting the company's stock price and market reputation.
- Participation Conditions: Affected investors must request to be appointed as lead plaintiff by February 9, 2026, and participation in the lawsuit incurs no costs, indicating the case could have significant implications for investor rights.
See More
